Catalyst Wire Dossier Catalyst Wire Dossier

Subretinal implantation of human embryonic stem cell-derived retinal pigment epithelium cells

· Regenerative Patch Technologies, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subretinal implantation of human embryonic stem cell-derived retinal pigment epithelium cells, covering 2020-05-29 to 2020-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD [Phase 1, Phase 2]

See pricing